HYBRID EVENT: You can participate in person at Orlando, Florida, USA or Virtually from your home or work.

6th Edition of Global Conference on

Addiction Medicine, Behavioral Health and Psychiatry

October 20-22, 2025 | Orlando, Florida, USA

Tranquilizers

Tranquilizers

Anti-anxiety drugs can sometimes be referred to as tranquillizers. The phrase was first used in 1953 to refer to medications that have a soothing effect. They are synthetic chemicals that are extremely beneficial for treating stress and mild to severe mental illnesses. They provide a person with a sense of well-being, relieving stress, tension, anxiety, and irritation. They are among the key ingredients in sleeping medications. There are several varieties of tranquillizers, and each one works in a unique way. For instance, noradrenaline is a tranquillizer that aids in boosting mood. When noradrenaline levels are low, signal-sending activity also decreases, which leads to a person feeling sad. Antidepressant medications under these circumstances.
There are two different types of tranquillizers.

  • Minor Calming Agents
  • Major Calming Agents

Anxiolytics, often known as minor tranquillizers, are used to alleviate anxiety and induce drowsiness. These medicines are now referred to as anti-anxiety meds. Neuroleptics, often known as major tranquillizers, were created to treat psychiatric diseases including schizophrenia. These medications fight delusions and other hallucinations. Major tranquillizers include phenothiazines, thioxanthones, butyrophenones, clozapine, and rauwolfia alkaloids, and are typically prescribed for lengthy periods of time. Even when used at the approved amounts, tranquillizers have the potential to produce adverse effects, just like any other pharmaceuticals. Low doses of moderate tranquillizers may result in sleepiness and coordination problems that resemble intoxication. These side effects often appear when the patient first starts taking the prescription, although they might also appear later if the medication accumulates.

Committee Members
Speaker at Addiction Medicine, Behavioral Health and Psychiatry 2025 - Nile Stanley

Nile Stanley

University of North Florida, United States
Speaker at Addiction Medicine, Behavioral Health and Psychiatry 2025 - Ann Marie Leonard Zabel

Ann Marie Leonard Zabel

Curry College, United States
Speaker at Addiction Medicine, Behavioral Health and Psychiatry 2025 - Denis Larrivee

Denis Larrivee

University of Navarra, Spain
GAB 2025 Speakers
Speaker at Addiction Medicine, Behavioral Health and Psychiatry 2025 - Scharbach Hugues

Scharbach Hugues

Paris University, France
Speaker at Addiction Medicine, Behavioral Health and Psychiatry 2025 - Alphonsus Obayuwana

Alphonsus Obayuwana

Triple-H Project LLC, United States
Speaker at Addiction Medicine, Behavioral Health and Psychiatry 2025 - Michelle Charbonnier

Michelle Charbonnier

MoNetwork, United States
Speaker at Addiction Medicine, Behavioral Health and Psychiatry 2025 - Monica Zuniga Fajuri

Monica Zuniga Fajuri

Tiburcio Vasquez Health Center, United States

Submit your abstract Today

Watsapp